Published in Women's Health Weekly, November 15th, 2001
Investigators at the Roswell Park Cancer Institute in New York report prostate epithelium-derived Ets transcription factor (PDEF) can be identified in breast cancer tumors and might be used as a vaccine antigen to prevent breast cancer.
"There is a need to identify novel breast tumor-associated molecules with a potential as diagnostic/prognostic markers of breast cancer as well as targets of vaccine and drug discovery against this cancer," A. Ghardersohi...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.